We are live on
!
Find out more
OFG
Oxford Financial Group Portfolio holdings
AUM
$1.86B
1-Year Est. Return
19.25%
This Fund
S&P 500
This Quarter
Est. Return
+6.34%
1 Year Est. Return
+19.25%
3 Year Est. Return
+80.37%
5 Year Est. Return
+94.42%
10 Year Est. Return
–
AUM
$721M
AUM Growth
+$31M
(+4.5%)
Cap. Flow
-$6.1M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
67.76%
Holding
242
New
25
Increased
48
Reduced
74
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$5.77M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$2.74M |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$2.3M |
| 4 |
Eaton
ETN
|
+$1.58M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$6.34M |
| 2 |
Corcept Therapeutics
CORT
|
+$5.42M |
| 3 |
CERN
Cerner Corp
CERN
|
+$2.4M |
| 4 |
Leggett & Platt
LEG
|
+$1.09M |
| 5 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$925K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.28% |
| 2 | Financials | 5.97% |
| 3 | Consumer Discretionary | 2.52% |
| 4 | Technology | 2.24% |
| 5 | Industrials | 1.13% |
Similar funds
CFA
SG
JSAM
GRA
CP
WRBC
ACM
EAM
Oxford Financial Group's Q1 2021 Portfolio in Review
As of Q1 2021, Oxford Financial Group held 242 positions worth $721M, up 4.5% from $690M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Oxford Financial Group's Q1 2021 filing shows 25 new, 48 increased, 74 reduced and 23 closed positions. Its largest new stake was iShares MSCI USA Value Factor ETF: 28,454 shares worth $2.92M. The largest sale was Eli Lilly, an estimated $6.34M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
- Oxford Financial Group's largest Q1 2021 buy was iShares MSCI USA Value Factor ETF: 28,454 shares worth $2.92M.
- Oxford Financial Group added most to Vanguard Morningstar Total Stock Market ETF in Q1 2021, an estimated $5.77M increase.
- Oxford Financial Group's biggest Q1 2021 reduction was Eli Lilly, cutting an estimated $6.34M.
- Oxford Financial Group fully exited Corcept Therapeutics in Q1 2021, selling an estimated $5.42M.
- Oxford Financial Group's ten largest holdings make up 68% of its $721M portfolio in Q1 2021.
- Oxford Financial Group opened 25 new positions and closed 23 in Q1 2021.
- Oxford Financial Group's portfolio value rose 4.5% quarter-over-quarter to $721M.
Based on Oxford Financial Group's 13F filing for Q1 2021, filed 10 May 2021.